ATP2B3
Plasma membrane calcium-transporting ATPase 3
Also known as: AT2B3_HUMAN, CFAP39, CLA2, PMCA3, SCAX1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16720
- Gene
- ATP2B3
- Ensembl
- ENSG00000067842
- Chromosome
- X
- Canonical length
- 1220 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 3. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1220 residues, UniProt reviewed canonical sequence.
>Q16720|ATP2B3
1 MGDMANSSIE FHPKPQQQRD VPQAGGFGCT LAELRTLMEL RGAEALQKIE EAYGDVSGLC
61 RRLKTSPTEG LADNTNDLEK RRQIYGQNFI PPKQPKTFLQ LVWEALQDVT LIILEVAAIV
121 SLGLSFYAPP GEESEACGNV SGGAEDEGEA EAGWIEGAAI LLSVICVVLV TAFNDWSKEK
181 QFRGLQSRIE QEQKFTVIRN GQLLQVPVAA LVVGDIAQVK YGDLLPADGV LIQANDLKID
241 ESSLTGESDH VRKSADKDPM LLSGTHVMEG SGRMVVTAVG VNSQTGIIFT LLGAGGEEEE
301 KKDKKGKQQD GAMESSQTKA KKQDGAVAME MQPLKSAEGG EMEEREKKKA NAPKKEKSVL
361 QGKLTKLAVQ IGKAGLVMSA ITVIILVLYF VIETFVVEGR TWLAECTPVY VQYFVKFFII
421 GVTVLVVAVP EGLPLAVTIS LAYSVKKMMK DNNLVRHLDA CETMGNATAI CSDKTGTLTT
481 NRMTVVQSYL GDTHYKEIPA PSALTPKILD LLVHAISINS AYTTKILPPE KEGALPRQVG
541 NKTECALLGF VLDLKRDFQP VREQIPEDKL YKVYTFNSVR KSMSTVIRMP DGGFRLFSKG
601 ASEILLKKCT NILNSNGELR GFRPRDRDDM VRKIIEPMAC DGLRTICIAY RDFSAGQEPD
661 WDNENEVVGD LTCIAVVGIE DPVRPEVPEA IRKCQRAGIT VRMVTGDNIN TARAIAAKCG
721 IIQPGEDFLC LEGKEFNRRI RNEKGEIEQE RLDKVWPKLR VLARSSPTDK HTLVKGIIDS
781 TTGEQRQVVA VTGDGTNDGP ALKKADVGFA MGIAGTDVAK EASDIILTDD NFTSIVKAVM
841 WGRNVYDSIS KFLQFQLTVN VVAVIVAFTG ACITQDSPLK AVQMLWVNLI MDTFASLALA
901 TEPPTESLLL RKPYGRDKPL ISRTMMKNIL GHAVYQLAII FTLLFVGELF FDIDSGRNAP
961 LHSPPSEHYT IIFNTFVMMQ LFNEINARKI HGERNVFDGI FSNPIFCTIV LGTFGIQIVI
1021 VQFGGKPFSC SPLSTEQWLW CLFVGVGELV WGQVIATIPT SQLKCLKEAG HGPGKDEMTD
1081 EELAEGEEEI DHAERELRRG QILWFRGLNR IQTQIRVVKA FRSSLYEGLE KPESKTSIHN
1141 FMATPEFLIN DYTHNIPLID DTDVDENEER LRAPPPPSPN QNNNAIDSGI YLTTHVTKSA
1201 TSSVFSSSPG SPLHSVETSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2B3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 106 nTPM
- cerebellum: 15 nTPM
- cerebral cortex: 13 nTPM
- adrenal gland: 9.2 nTPM
- basal ganglia: 8 nTPM
- hippocampal formation: 7 nTPM
Single-cell type
- choroid plexus epithelial cells: 197 nCPM
- adrenal medulla cells: 32 nCPM
- brain inhibitory neurons: 32 nCPM
- brain excitatory neurons: 30 nCPM
- epididymal efferent duct ciliated cells: 21 nCPM
- extravillous trophoblasts: 21 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 503 nTPM
- cerebral cortex: 134 nTPM
- hippocampal formation: 104 nTPM
- white matter: 74 nTPM
- pons: 60 nTPM
- cerebellum: 52 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP2B3.
Disease | AllUniProt
Conditions ATP2B3 is implicated in, by any mechanism.
- Spinocerebellar ataxia, X-linked 1 (SCAX1) MIM:302500
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 257 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- X-linked progressive cerebellar ataxia
- Aldosterone-producing adrenal cortex adenoma
- Inborn genetic diseases
- 8 conditions
- Arthrogryposis multiplex congenita
Disease | ImmuneIEDB
Conditions an epitope on ATP2B3 was assayed in.
- lung adenocarcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.75
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion export across plasma membrane
- monoatomic ion transmembrane transport
- regulation of cardiac conduction
- regulation of cytosolic calcium ion concentration
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium ion transmembrane transporter activity
- calmodulin binding
- metal ion binding
- P-type calcium transporter activity
- P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, subfamily IIB
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- Plasma membrane calcium transporting P-type ATPase, C-terminal
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- Plasma membrane calcium transporter ATPase C terminal
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP2B3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2B3 as an antibody target. Whether an autoantibody or antibody against ATP2B3 could matter depends on whether native ATP2B3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2B3 is annotated at the cell surface, where native ATP2B3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP2B3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...